We’ve been featured in Motherhood Moments! Check out a summary below and some key points. Be sure to check out the full article. 

Proactive on Gut Health 

As scientific evidence of beneficial effects on human health has continually expanded in the last two decades, probiotic bacteria have become increasingly popular. Consequently, they have been used in a variety of products, and the food industry has been very active in studying and promoting them. Aside from the gut, the mouth and airways host the greatest number of probiotics, living microorganisms that contribute to a variety of health benefits. Several researchers have investigated the benefits that can be obtained from introducing more probiotics into the system as a way to understand the importance of good bacteria. As a result of these studies, we’ve discovered that allergies can be attributed to an oral probiotic deficiency. 

The Future of Allergy Relief: Investing in the Future

An allergy results from your immune system’s reaction to a substance. It’s characterized by a variety of physiological reactions, from mild symptoms such as a runny nose or itchy eyes to severe reactions such as anaphylaxis. The development of allergies may begin later in life, and a physician may be required to determine exactly what the patient is allergic to. The Allerpops team has developed a way to help allergy sufferers with expertly crafted, FDA-approved ingredients that have been molded deliciously into … a popsicle! 


We developed these probiotic popsicles following a longitudinal, cross-sectional, and translational study that identified the cause of a test subject’s allergies as well as the absence of beneficial bacteria, Streptococcus and Veilonella, in the test subject’s oral/nasal cavities. The discovery led us to develop a prebiotic mix that supported these necessary probiotics, and the combination caused our test subject’s allergies to disappear completely. 

Invest In All-Natural Allergy Relief

To further research to help the 50 million allergy sufferers in the US and 30% of the global population, AllerPops has invested additional funds in a double-blind, placebo-controlled clinical trial by an independent research company that has validated their efficacy.


Invest with Allerpops today on WeFunder as we are poised to disrupt the $4 Billion global allergy relief market.